IART FY 2025 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.6B+1.5% YoY

Gross Profit

$845M51.7% margin

Operating Income

$68M4.2% margin

Net Income

-$516M-31.6% margin

EPS (Diluted)

$-6.73

Cash Flow

Operating Cash Flow

$50M

Free Cash Flow

-$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.6B

Total Liabilities

$2.6B

Stockholders' Equity

$1.0B

Cash & Equivalents

$235M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.6B	+1.5%
Gross Profit	$845M	$882M	-4.2%
Operating Income	$68M	$28M	+140.5%
Net Income	-$516M	-$7M	-7337.7%